"The US Food and Drug Administration (FDA) approved daclizumab (Zinbryta, Biogen Idec) today for treatment of patients with relapsing forms of multiple sclerosis (MS), according to an FDA news release.
The agency cautions, how"...
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 1/22/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional Baclofen Information
Baclofen - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.